Barbara Renga
About
Barbara Renga is a scholar working on Oncology, Surgery and Molecular Biology.
According to data from OpenAlex, Barbara Renga has authored 108 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 38 papers in Surgery and 25 papers in Molecular Biology. Recurrent topics in Barbara Renga's work include Drug Transport and Resistance Mechanisms (43 papers), Cholesterol and Lipid Metabolism (19 papers) and Liver Disease Diagnosis and Treatment (14 papers). Barbara Renga is often cited by papers focused on Drug Transport and Resistance Mechanisms (43 papers), Cholesterol and Lipid Metabolism (19 papers) and Liver Disease Diagnosis and Treatment (14 papers). Barbara Renga collaborates with scholars based in Italy, United States and United Kingdom. Barbara Renga's co-authors include Stefano Fiorucci, Andrea Mencarelli, Eleonora Distrutti, Sabrina Cipriani, Claudio D’Amore, Elisabetta Antonelli, Antonio Morelli, Stefano Orlandi, Angela Zampella and Roberto Pellicciari and has published in prestigious journals such as Circulation, The Journal of Immunology and Gastroenterology.
In The Last Decade
Barbara Renga
107 papers receiving 6.9k citations
Hit Papers
Peers
Barbara Renga
Andrea Mencarelli Italy
Eleonora Distrutti Italy
Patrick Maurel France
Olivier Barbier Canada
Hiroshi Kono Japan
Jashvant D. Unadkat United States
Stephan Krähenbühl Switzerland
Geny M. M. Groothuis Netherlands
Hiroyuki Kusuhara Japan
W. Gerok Germany
Citations per year, relative to Barbara Renga Barbara Renga (= 1×)
peers
Andrea Mencarelli
Countries citing papers authored by Barbara Renga
Since
Specialization
Citations
This map shows the geographic impact of Barbara Renga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Renga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Renga more than expected).
Fields of papers citing papers by Barbara Renga
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Barbara Renga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Renga. The network helps show where Barbara Renga may publish in the future.
Co-authorship network of co-authors of Barbara Renga
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Renga. A scholar is included among the top collaborators of Barbara Renga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Renga. Barbara Renga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Leva, Francesco Saverio Di, Carmen Festa, Barbara Renga, et al.. (2015). Structure-based drug design targeting the cell membrane receptor GPBAR1: exploiting the bile acid scaffold towards selective agonism. Scientific Reports. 5(1). 16605–16605.
2.
Renga, Barbara, Daniela Francisci, Adriana Carino, et al.. (2015). The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma. Scientific Reports. 5(1). 15403–15403.
3.
Renga, Barbara, Carmen Festa, Simona De Marino, et al.. (2015). Molecular decodification of gymnemic acids from Gymnema sylvestre. Discovery of a new class of liver X receptor antagonists. Steroids. 96. 121–131.
4.
Renga, Barbara, et al.. (2015). Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1. PLoS ONE. 10(11). e0141082–e0141082.
5.
Cipriani, Sabrina, Barbara Renga, Claudio D’Amore, et al.. (2015). Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling. PLoS ONE. 10(7). e0129866–e0129866.
6.
Chianese, Giuseppina, Valentina Sepe, Vittorio Limongelli, et al.. (2014). Incisterols, highly degraded marine sterols, are a new chemotype of PXR agonists. Steroids. 83. 80–85.
7.
Micco, Simone Di, Barbara Renga, Adriana Carino, et al.. (2013). Structural insights into Estrogen Related Receptor-β modulation: 4-Methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. Steroids. 80. 51–63.
8.
Renga, Barbara, Andrea Mencarelli, Claudio D’Amore, et al.. (2012). Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis. PLoS ONE. 7(1). e30443–e30443.
9.
Swanson, Hollie I., Taira Wada, Wen Xie, et al.. (2012). Role of Nuclear Receptors in Lipid Dysfunction and Obesity-Related Diseases. Drug Metabolism and Disposition. 41(1). 1–11.
10.
Sepe, Valentina, Maria Valeria D’Auria, Gianluigi Lauro, et al.. (2012). Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist. Organic & Biomolecular Chemistry. 10(31). 6350–6350.
11.
Mencarelli, Andrea, Sabrina Cipriani, Barbara Renga, et al.. (2012). VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. PLoS ONE. 7(9). e45425–e45425.
12.
Renga, Barbara, Daniela Francisci, Claudio D’Amore, et al.. (2012). The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes. PLoS ONE. 7(4). e35924–e35924.
13.
Renga, Barbara, Andrea Mencarelli, Marco Migliorati, et al.. (2011). SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts. Inflammation Research. 60(6). 577–587.
14.
Renga, Barbara, Andrea Mencarelli, Marco Migliorati, Eleonora Distrutti, & Stefano Fiorucci. (2009). Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World Journal of Gastroenterology. 15(17). 2097–2097.
15.
Renga, Barbara, Marco Migliorati, Andrea Mencarelli, & Stefano Fiorucci. (2009). Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(6). 564–573.
16.
Mencarelli, Andrea, Barbara Renga, Giuseppe Palladino, Eleonora Distrutti, & Stefano Fiorucci. (2009). The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. Biochemical Pharmacology. 78(9). 1214–1223.
17.
Rizzo, Gianluca, Barbara Renga, Andrea Mencarelli, R. Pellicciari, & Stefano Fiorucci. (2005). Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases. PubMed. 5(3). 289–303.
18.
Rizzo, Giovanni, Barbara Renga, Elisabetta Antonelli, et al.. (2005). The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes. Molecular Pharmacology. 68(2). 551–558.
19.
Fiorucci, Stefano, Giovanni Rizzo, Elisabetta Antonelli, et al.. (2005). A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 314(2). 584–595.
20.
Fiorucci, Stefano, Andrea Mencarelli, Alessandra Meneguzzi, et al.. (2004). Co-Administration of Nitric Oxide-Aspirin (NCX-4016) and Aspirin Prevents Platelet and Monocyte Activation and Protects Against Gastric Damage Induced by Aspirin in Humans. Journal of the American College of Cardiology. 44(3). 635–641.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Andrea Mencarelli Breakdown of academic impact, for papers by Eleonora Distrutti Breakdown of academic impact, for papers by Patrick Maurel Breakdown of academic impact, for papers by Olivier Barbier Breakdown of academic impact, for papers by Hiroshi Kono Breakdown of academic impact, for papers by Jashvant D. Unadkat Breakdown of academic impact, for papers by Stephan Krähenbühl Breakdown of academic impact, for papers by Geny M. M. Groothuis Breakdown of academic impact, for papers by Hiroyuki Kusuhara Breakdown of academic impact, for papers by W. Gerok